Skip to main content
. Author manuscript; available in PMC: 2013 Dec 7.
Published in final edited form as: J Proteome Res. 2012 Oct 30;11(12):5592–5601. doi: 10.1021/pr300796m

Table 2.

Characteristics of Different Biobank Collection Types

Description Cost Appropriate for general use
Individual Clinicians with access to
specimens set aside “unused”
samples for future research
not yet specified
Low Low
Often not processed under standardized conditions
Often not well annotated
Not publicized, and therefore difficult to access
Specific
projects
Specific research project with
defined needs (and often a
budget) for samples
Moderate Moderate to low
Likely collected under conditions appropriate for
the defined project. Amount of sample may be
limited. Collections not usually publicized, so
difficult to access
Grant
programs
Programs like SPORES,
Cancer Centers, Clinical
trials networks and Centers
of Excellence collect samples
for both defined projects and
some anticipated future
projects not yet specified
Moderate
to high
Moderate
For those collections that include support for
undefined future projects, these samples may be
useful. The collections are publicized within their
grant programs, but variably outside that circle.
Access procedures vary.
Formal
public
repository
Repository created to collect
samples for numerous
projects, including future
projects not yet specified.
Such repositories often have
a specific theme (e.g., disease
genetics).
High Moderate to High
Samples collected with best practices and under
standardized conditions, well-defined storage
conditions, well annotated, well publicized with
defined access procedures, sample types may limit
application to specific research type (e.g., blood
only); may include restrictions on access (e.g.,
limited to researchers in a specific country).